| Previous Close | 3.55 |
| Open | 3.60 |
| Bid | 3.63 x 600 |
| Ask | 3.64 x 500 |
| Day's Range | 3.58 - 3.79 |
| 52 Week Range | 1.20 - 8.09 |
| Volume | 485,129 |
| Avg. Volume | 1,128,171 |
| Market Cap | 270.68M |
| Beta | 0.78 |
| PE Ratio (TTM) | -5.64 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool•10 days ago
Here's What Caused Arrowhead Pharmaceuticals' Stock to Spike Today
The announcement of a new RNAi drug-development platform has traders feeling a bit giddy about the clinical-stage biotech.
- Capital Cube•14 days ago
ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : September 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Arrowhead Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ARWR-US. Comparing the performance and risk of Arrowhead Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Capital Cube•17 days agoArrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017
Categories: Yahoo FinanceGet free summary analysis Arrowhead Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Arrowhead Pharmaceuticals, Inc. – Alnylam Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc., Johnson & Johnson, Shire PLC Sponsored ADR, Ligand Pharmaceuticals Incorporated, Nanophase Technologies Corporation, Inovio Pharmaceuticals, Inc., Abeona Therapeutics, ... Read more (Read more...)
